

Settlement resolves litigation pending since November 2023 that had constrained the Company's access to capital and to pursue strategic opportunities

Spyglass Pharma (NASDAQ: SGP - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Institutional and Insider Ownership 24.2% of Longevity

MiniMed Group (NASDAQ: MMED - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report) are both manufacturing companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Profitability This table compares MiniMed Group and Longevity

Longevity Health (NASDAQ: XAGE - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends. Analyst Recommendations This is a breakdown of

PITTSBURGH, March 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB: XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling businesses and executing value-creating transactions," said Rajiv Shukla, outgoing Chairman and Chief Executive Officer.

Spyglass Pharma (NASDAQ: SGP - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Analyst Recommendations This is a summary of

Check-Cap (NASDAQ: MBAI - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends. Profitability This table compares Check-Cap and Longevity Health's

Longevity Health (NASDAQ: XAGE - Get Free Report) and Predictive Oncology (NASDAQ: AGPU - Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Insider and Institutional Ownership 24.2% of Longevity